KA

Kayamuddin Ansari

Active Director Director DIN 11467725
DIN 11467725 First appointment Jan 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Kayamuddin Ansari

Data last updated:

Kayamuddin Ansari is a Director at Curix Pharma Private Limited (since 2026).

DIN 11467725
Primary Designation Director
First Appointment 06 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Curix Pharma Private Limited U21000DL2026PTC461167
Director06 Jan 20262026Active

Board colleagues of Kayamuddin Ansari

NameDINCompanyDesignation
Amanjeet Kumar11467727Curix Pharma Private LimitedDirector
Tahreen Saba11467726Curix Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Curix Pharma Private Limited
Premium access

Shareholding and investment profile for Kayamuddin Ansari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kayamuddin Ansari

Kayamuddin Ansari currently holds 1 directorship: Curix Pharma Private Limited (Director, since 06 Jan 2026).

Kayamuddin Ansari was first appointed on 06 Jan 2026 as Director at Curix Pharma Private Limited.

The current boards of Kayamuddin Ansari's companies include Amanjeet Kumar (Curix Pharma Private Limited), Tahreen Saba (Curix Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available